30% OFF for orders above $299! Use code: BEST30

The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides)

$79.99

Rated 5.00 out of 5 based on 20 customer ratings
Guaranteed Safe Checkout

New Year Sale!

  • 30% OFF for orders above $299! Use code: BEST30

Description

Course Overview

Gain essential knowledge with The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology. This dynamic online CME course delivers the latest insights in oncology management through expert-led, case-based presentations designed to strengthen clinical decision-making and board exam readiness.

Continuing Medical Education Focus Areas

  • Infections in Cancer Patients
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia and Amyloidosis
  • Head and Neck Cancers
  • Management of Non Small Cell Lung Cancer
  • Carcinoid and Neuroendocrine Tumors
  • Novel Approaches to Esophageal and Gastric Cancer Management
  • And many more…

Topics & Speakers

  • Molecular Genetics of Cancer – Marios Giannakis, MD, PhD
  • Infections in Cancer Patients – Lindsey Baden, MD
  • Opioid Prescribing for Cancer-Related Pain – Kate M. Lally, MD
  • Communication – The Key to Excellence in End-of-Life Care – Eilann C. Santo, MD, MPH
  • Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes – Zuzana Tothova, MD, PhD
  • The Evolving Treatment Landscape of the Acute Leukemias – Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome – Eric S. Winer, MD
  • Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
  • Myeloproliferative Syndromes – Joan-Chi How, MD
  • Multiple Myeloma – Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulinemia and Amyloidosis – Jorge J. Castillo, MD
  • Low Grade Lymphomas – Caron A. Jacobson, MD
  • Non-Hodgkin’s Lymphoma – Diffuse Large B-Cell and Burkitt – Eric D. Jacobsen, MD
  • Non-Hodgkin Lymphoma – Mantle Cell and T-Cell – Eric D. Jacobsen, MD
  • Hodgkin’s Lymphoma – Reid W. Merryman, MD
  • Diagnosis and Treatment of CLL and Related B-Cell Malignancies – Matthew S. Davids, MD
  • Head and Neck Cancer – Kartik Sehgal, MD
  • Thyroid Cancer – Kartik Sehgal, MD
  • Natural History, Screening, and Small Cell Lung Cancer – Jacob M. Sands, MD
  • Management of Stage I-III Non Small Cell Lung Cancer – Julia Rotow, MD
  • Management of Metastatic Non Small Cell Lung Cancer – Julia Rotow, MD
  • Mesothelioma and Thymic Malignancies – David Kwiatkowski, MD, PhD
  • Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
  • Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
  • Pancreatic Cancer – Brian M. Wolpin, MD
  • Hepatobiliary Cancers Board Review – James M. Cleary, MD, PhD
  • Management of Localized Colorectal Cancer – Douglas A. Rubinson, MD, PhD
  • Metastatic Colorectal Cancer – Leah H. Biller, MD
  • Gastrointestinal Cancer Genetics – Asaf Maoz, MD
  • Prostate, Bladder, and Testicular Cancer – Mark M. Pomerantz, MD
  • Key Updates in Urothelial Carcinoma – Bradley A. McGregor, MD
  • Key Updates in Renal Cell Carcinoma – Bradley A. McGregor, MD
  • Prostate Cancer Part I – Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD
  • Prostate Cancer Part II – Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD
  • Melanoma – F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
  • Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD
Shopping Cart
The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides)The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides)
$79.99
Scroll to Top